Company Filing History:
Years Active: 2014-2015
Title: Mami Yamazaki: Innovator in Gastrointestinal Therapeutics
Introduction
Mami Yamazaki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing therapeutic agents for gastrointestinal disorders. With a focus on safety and efficacy, his work has the potential to improve the quality of life for many patients.
Latest Patents
Mami Yamazaki holds 2 patents that showcase his innovative approach to drug development. His latest patents include:
1. **Piperazinyl cyclohexane compounds as GPR38 agonists** - This invention aims to find a therapeutic and/or prophylactic agent for gastrointestinal disorders, emphasizing excellent activity and high safety. The compound is represented by a general formula that includes various substituents and functional groups.
2. **Piperazinyl methyl phenyl cyclohexane compound** - Similar to his first patent, this compound also targets gastrointestinal disorders, focusing on safety and efficacy. The general formula includes a range of substituents, highlighting the complexity and potential of the compound.
Career Highlights
Mami Yamazaki is currently associated with Daiichi Sankyo Company, Limited, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing safe and effective treatments for gastrointestinal issues.
Collaborations
Mami collaborates with talented colleagues, including Narihiro Toda and Rieko Takano, who contribute to his research and development efforts. Their teamwork enhances the potential for groundbreaking discoveries in the field.
Conclusion
Mami Yamazaki's contributions to pharmaceutical innovations, particularly in gastrointestinal therapeutics, demonstrate his dedication to improving patient care. His patents reflect a commitment to safety and efficacy, positioning him as a key figure in the industry.